MA
REGN icon

MUFG Americas’s Regeneron Pharmaceuticals REGN Stock Holding History

MUFG Americas’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-330
Closed -$227K – 647
2022
Q3 		$227K Sell
330
-512
-61% -$322K 0.01% 365
2022
Q2 		$498K Sell
842
-80
-9% -$52K 0.01% 310
2022
Q1 		$644K Sell
922
-64
-6% -$40.5K 0.01% 294
2021
Q4 		$623K Sell
986
-56
-5% -$34.4K 0.01% 305
2021
Q3 		$631K Sell
1,042
-248
-19% -$154K 0.01% 296
2021
Q2 		$721K Sell
1,290
-396
-23% -$201K 0.01% 288
2021
Q1 		$798K Sell
1,686
-1,376
-45% -$670K 0.01% 291
2020
Q4 		$1.48M Sell
3,062
-2,393
-44% -$1.29M 0.03% 249
2020
Q3 		$3.05M Sell
5,455
-485
-8% -$294K 0.08% 186
2020
Q2 		$3.71M Sell
5,940
-6,094
-51% -$3.46M 0.11% 168
2020
Q1 		$5.88M Sell
12,034
-2,624
-18% -$1.08M 0.2% 124
2019
Q4 		$5.5M Buy
14,658
+477
+3% +$160K 0.14% 154
2019
Q3 		$3.93M Buy
14,181
+1,590
+13% +$471K 0.11% 177
2019
Q2 		$3.94M Buy
12,591
+3,344
+36% +$1.11M 0.11% 182
2019
Q1 		$3.8M Buy
9,247
+7,202
+352% +$2.97M 0.11% 177
2018
Q4 		$764K Buy
+2,045
New +$749K 0.02% 278
2015
Q4 		– Sell
-9
Closed -$4K – 1175
2015
Q3 		$4K Buy
+9
New +$4.83K ﹤0.01% 1002
2015
Q2 		– Sell
-30
Closed -$14K – 1256
2015
Q1 		$14K Sell
30
-15
-33% -$6.36K ﹤0.01% 868
2014
Q4 		$18K Sell
45
-22
-33% -$8.65K ﹤0.01% 844
2014
Q3 		$24K Hold
67
– – ﹤0.01% 793
2014
Q2 		$19K Sell
67
-13
-16% -$3.85K ﹤0.01% 852
2014
Q1 		$24K Buy
+80
New +$24.6K ﹤0.01% 795

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MUFG Americas's REGN Position: Q4 2022 in Review

MUFG Americas sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 330 shares — an estimated $227K sold.

MUFG Americas first reported a position in REGN in Q1 2014 and held it in 22 quarters. The position peaked at $5.88M in Q1 2020. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • MUFG Americas reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • MUFG Americas sold 330 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $227K.
  • MUFG Americas first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 22 quarters.
  • MUFG Americas's Regeneron Pharmaceuticals position peaked at $5.88M in Q1 2020.
  • 1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.